Differential Mortality Outcomes in Real-world Patients with Lean, Nonobese, and Obese Nonalcoholic Fatty Liver Disease.
Vy H NguyenAudrey HaNicholas Ajit RouillardRichard Hieu LeAshley FongSurya GudapatiJung Eun ParkMayumi MaedaScott BarnettRamsey CheungMindie H NguyenPublished in: Journal of clinical and translational hepatology (2023)
Lean NAFLD had fewer metabolic comorbidities but similar adverse or worse outcomes, suggesting that it is not benign. Healthcare providers should provide the same level of care and intervention as for overweight and obese NAFLD.
Keyphrases
- healthcare
- randomized controlled trial
- palliative care
- adipose tissue
- bone mineral density
- metabolic syndrome
- cardiovascular events
- type diabetes
- weight loss
- emergency department
- pain management
- bariatric surgery
- cardiovascular disease
- postmenopausal women
- obese patients
- liver fibrosis
- electronic health record
- social media
- glycemic control